Screening for prostate cancer

Steven R. Gambert

doi:10.1023/A:1015290429403

Screening for prostate cancer

Steven R. Gambert

Research output: Contribution to journal › Review article › peer-review

14 Scopus citations

Abstract

Carcinoma of the prostate gland is the second most common cancer among men with an age-adjusted incidence of 635 cases per 100,000 men aged 65 and older. While there are several proven methods for detecting prostate cancer, debate continues as to the best way to detect it early as well as who should receive particular screening. There are differing opinions as to proven benefit even when cancer is detected. Fortunately, newer methods continue to be developed that will hopefully reduce false positive detection rates while insuring an adequate level of screening protection.

Original language	English (US)
Pages (from-to)	249-257
Number of pages	9
Journal	International urology and nephrology
Volume	33
Issue number	2
DOIs	https://doi.org/10.1023/A:1015290429403
State	Published - 2001
Externally published	Yes

Keywords

PSA
Prostate cancer
Screening

ASJC Scopus subject areas

Nephrology
Urology

Access to Document

10.1023/A:1015290429403

Cite this

@article{55281c8c46644b4daddd36a95b2af8bb,

title = "Screening for prostate cancer",

abstract = "Carcinoma of the prostate gland is the second most common cancer among men with an age-adjusted incidence of 635 cases per 100,000 men aged 65 and older. While there are several proven methods for detecting prostate cancer, debate continues as to the best way to detect it early as well as who should receive particular screening. There are differing opinions as to proven benefit even when cancer is detected. Fortunately, newer methods continue to be developed that will hopefully reduce false positive detection rates while insuring an adequate level of screening protection.",

keywords = "PSA, Prostate cancer, Screening",

author = "Gambert, {Steven R.}",

year = "2001",

doi = "10.1023/A:1015290429403",

language = "English (US)",

volume = "33",

pages = "249--257",

journal = "International urology and nephrology",

issn = "0301-1623",

publisher = "Springer Netherlands",

number = "2",

}

TY - JOUR

T1 - Screening for prostate cancer

AU - Gambert, Steven R.

PY - 2001

Y1 - 2001

N2 - Carcinoma of the prostate gland is the second most common cancer among men with an age-adjusted incidence of 635 cases per 100,000 men aged 65 and older. While there are several proven methods for detecting prostate cancer, debate continues as to the best way to detect it early as well as who should receive particular screening. There are differing opinions as to proven benefit even when cancer is detected. Fortunately, newer methods continue to be developed that will hopefully reduce false positive detection rates while insuring an adequate level of screening protection.

AB - Carcinoma of the prostate gland is the second most common cancer among men with an age-adjusted incidence of 635 cases per 100,000 men aged 65 and older. While there are several proven methods for detecting prostate cancer, debate continues as to the best way to detect it early as well as who should receive particular screening. There are differing opinions as to proven benefit even when cancer is detected. Fortunately, newer methods continue to be developed that will hopefully reduce false positive detection rates while insuring an adequate level of screening protection.

KW - PSA

KW - Prostate cancer

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=0035527533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035527533&partnerID=8YFLogxK

U2 - 10.1023/A:1015290429403

DO - 10.1023/A:1015290429403

M3 - Review article

C2 - 12092637

AN - SCOPUS:0035527533

SN - 0301-1623

VL - 33

SP - 249

EP - 257

JO - International urology and nephrology

JF - International urology and nephrology

IS - 2

ER -

Screening for prostate cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this